Although IL‐6/JAK/STAT3 inhibitors have yet to be approved by the FDA for BC, there are several ongoing clinical trials evaluating the efficacy of compounds that inhibit this pathway in TNBC92, 93, 94, 95, 96, 97, 98 which could be useful in treating AA women. Here, IL6 is linked to breast cancer.